# Acufocus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/acufocus

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.acufocus.com
- Total disclosed funding: $114M
- Latest round: Series F (Feb 7, 2012)
- Investors on record: 7

## About

Acufocus, Inc. is a medical device company specializing in innovative ophthalmic solutions aimed at improving surgical outcomes in eye procedures, particularly in cataract and refractive surgery.Acufocus, Inc. is focused on developing and manufacturing advanced ophthalmic devices. Founded in 2001 and headquartered in Irvine, US, the company was acquired by Bausch & Lomb Optical Company on January 17, 2023, for USD 35 mn. Acufocus has completed a total of 14 deals, primarily targeting innovation in eye care solutions. The acquisition allows Bausch & Lomb to enhance its surgical portfolio.Acufocus, Inc. provides a range of innovative ophthalmic surgical solutions, focusing on enhancing outcomes for cataract and refractive surgeries. Their key products include the Stellaris Elite® Vision Enhancement System, a versatile dual-function platform, and the TENEO™ Excimer Laser, designed for advanced refractive surgeries. Additional offerings such as the Bi-Blade® Vitrectomy Cutter and enVista® Toric IOL cater to specific challenges in vitreoretinal and cataract surgeries, serving ophthalmic surgeons and healthcare facilities across various markets.Acufocus, Inc. generates revenue through direct sales of its ophthalmic surgical devices to healthcare providers including hospitals and surgical centers, mainly within the United States. The company operates through B2B transactions, which involve bulk orders and tailored equipment packages for surgical teams. The pricing reflects the sophisticated technology of their flagship products such as the Stellaris Elite® and TENEO™ systems. Ongoing partnerships with healthcare institutions further diversify their revenue streams as they seek continuous support and product updates.Following its acquisition by Bausch & Lomb Optical Company for USD 35 mn in January 2023, Acufocus, Inc. is set to expand its surgical product offerings and market reach. The integration into Bausch & Lomb's portfolio presents opportunities for introducing new ophthalmic devices. Plans for expanding into new markets are underway, particularly in regions with growing healthcare demands. The recent acquisition funding will support the development of innovative surgical solutions and enhance operational capabilities to meet the evolving needs of ophthalmic professionals.

## Funding rounds

- Series F, Feb 7, 2012, $40M — Carlyle Group, Versant Ventures, Accuitive Medical Ventures, SV Health Investors, Medtronic, Bausch + Lomb Corporation
- Series F, Nov 29, 2011, $65M — Carlyle Group, Versant Ventures, Healthcare Royalty Partners, Accuitive Medical Ventures, SV Health Investors, Medtronic
- Series B, Nov 13, 2002, $9M — Carlyle Group, Versant Ventures, SV Health Investors
- Seed, Jun 1, 2001 — SV Health Investors

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Seed, Series B, Series F
- Carlyle Group (https://capitalatlas.ai/funds/carlyle-group) — Series B, Series F
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B, Series F
- Healthcare Royalty Partners (https://capitalatlas.ai/funds/healthcare-royalty-partners) — Series F
- Accuitive Medical Ventures (https://capitalatlas.ai/funds/accuitive-medical-ventures) — Series F
- Medtronic — Series F
- Bausch + Lomb Corporation — Series F